• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021

cafead

Administrator
Staff member
  • cafead   May 05, 2023 at 12:22: PM
via Acelyrin has raised $540 million in an initial public offering, the largest for a biotechnology startup since early 2021 and one of only a handful by young drugmakers this year.

article source
 

<